These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 32870149

  • 21. Levels of angiotensin II type-1 receptor antibodies and endothelin-1 type-A receptor antibodies correlate with antibody-mediated rejection and poor graft function in kidney-transplantation patients.
    Liu C, Kang ZY, Yin Z, Xiao Y, Liu W, Zhao Y, Li DH.
    Transpl Immunol; 2022 Oct; 74():101674. PubMed ID: 35901953
    [Abstract] [Full Text] [Related]

  • 22. The early impact of preformed angiotensin II type 1 receptor antibodies on graft function in a low immunological risk cohort of kidney transplant recipients.
    Sorohan BM, Ismail G, Berechet A, Obrișcă B, Constantinescu I, Mărunțelu I, Tacu D, Baston C, Sinescu I.
    Transpl Immunol; 2021 Jun; 66():101389. PubMed ID: 33838295
    [Abstract] [Full Text] [Related]

  • 23. Kidney re-transplantation in a child across the barrier of persisting angiotensin II type I receptor antibodies.
    Gold A, Fichtner A, Choukair D, Schmitt CP, Süsal C, Dragun D, Tönshoff B.
    Pediatr Nephrol; 2021 Mar; 36(3):725-729. PubMed ID: 33355703
    [Abstract] [Full Text] [Related]

  • 24. Acute kidney transplant rejection mediated by angiotensin II type 1 receptor antibodies in a pediatric hyperimmune patient.
    Guzzo I, Morolli F, Camassei FD, Piazza A, Poggi E, Dello Strologo L.
    Pediatr Nephrol; 2017 Jan; 32(1):185-188. PubMed ID: 27752765
    [Abstract] [Full Text] [Related]

  • 25. ARHGDIB and AT1R autoantibodies are differentially related to the development and presence of chronic antibody-mediated rejection and fibrosis in kidney allografts.
    Betjes MGH, Sablik KA, Litjens NHR, Otten HG, de Weerd AE.
    Hum Immunol; 2021 Feb; 82(2):89-96. PubMed ID: 33358038
    [Abstract] [Full Text] [Related]

  • 26. Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation.
    Pearl MH, Zhang Q, Palma Diaz MF, Grotts J, Rossetti M, Elashoff D, Gjertson DW, Weng P, Reed EF, Tsai Chambers E.
    Kidney Int; 2018 Jan; 93(1):260-269. PubMed ID: 28927645
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome.
    Reinsmoen NL, Mirocha J, Ensor CR, Marrari M, Chaux G, Levine DJ, Zhang X, Zeevi A.
    Transplantation; 2017 Jun; 101(6):1215-1221. PubMed ID: 27973391
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
    Schwaiger E, Eskandary F, Kozakowski N, Bond G, Kikić Ž, Yoo D, Rasoul-Rockenschaub S, Oberbauer R, Böhmig GA.
    Nephrol Dial Transplant; 2016 Aug; 31(8):1342-51. PubMed ID: 27190362
    [Abstract] [Full Text] [Related]

  • 31. Angiotensin II Type-1 Receptor Antibodies Are Associated With Active Allograft Dysfunction Following Pediatric Liver Transplantation.
    Wozniak LJ, Hickey MJ, Chan AP, Venick RS, Farmer DG, Busuttil RW, Reed EF, McDiarmid SV.
    Transplantation; 2020 Dec; 104(12):2547-2556. PubMed ID: 32101982
    [Abstract] [Full Text] [Related]

  • 32. Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies.
    Philogene MC, Bagnasco S, Kraus ES, Montgomery RA, Dragun D, Leffell MS, Zachary AA, Jackson AM.
    Transplantation; 2017 Mar; 101(3):608-615. PubMed ID: 27222934
    [Abstract] [Full Text] [Related]

  • 33. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D, Bach C, Staudner C, Böger CA, Bergler T, Banas B, Spriewald BM.
    Nephrol Dial Transplant; 2017 Apr 01; 32(4):730-737. PubMed ID: 28339671
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The impact of angiotensin II type 1 receptor antibodies on post-heart transplantation outcome in Heart Mate II bridged recipients.
    Urban M, Slavcev A, Gazdic T, Ivak P, Besik J, Netuka I.
    Interact Cardiovasc Thorac Surg; 2016 Mar 01; 22(3):292-7. PubMed ID: 26675563
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Preformed Angiotensin II Type-1 Receptor Antibodies Are Associated With Rejection After Kidney Transplantation: A Single-Center, Cohort Study.
    Kim D, Gimferrer I, Warner P, Nelson K, Sibulesky L, Bakthavatsalam R, Leca N.
    Transplant Proc; 2018 Dec 01; 50(10):3467-3472. PubMed ID: 30577222
    [Abstract] [Full Text] [Related]

  • 38. Detection of Angiotensin II type I-receptor antibodies in transplant glomerulopathy.
    Bussolino S, Dolla C, Ariaudo C, Civiletti F, Messina M, Mella A, Caorsi C, Amoroso A, Barreca A, Papotti M, Giunti S, Fop F, Biancone L.
    Clin Transplant; 2018 Nov 01; 32(11):e13407. PubMed ID: 30218593
    [Abstract] [Full Text] [Related]

  • 39. Effect of anti-angiotensin II type 1 receptor antibodies on the outcomes of kidney transplantation: a systematic review and meta-analysis.
    Kang ZY, Liu C, Liu W, Li DH.
    Nephrol Dial Transplant; 2022 May 25; 37(6):1171-1180. PubMed ID: 34865146
    [Abstract] [Full Text] [Related]

  • 40. Rejection and graft outcomes in kidney transplant recipients with and without angiotensin II receptor type 1 antibodies.
    Aljishi M, Isbel NM, Jegatheesan D, Johnson DW, Cho Y, Campbell SB, Hawley CM, Thornton A, Gillis D, Johnstone K.
    Transpl Immunol; 2023 Feb 25; 76():101756. PubMed ID: 36460263
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.